USFDA approves Carvykti for patients with Relapsed or Refractory Multiple Myeloma who have received at least one prior line of therapy
The USFDA has approved Carvykti for patients with Relapsed or Refractory Multiple…
StartUPDATES: New Developments from Healthcare Startups
At the LSI 2024 Emerging MedTech Summit, Alpha Sophia announced that their…
HSE structural reform about ‘the centre letting go’ – CEO
The CEO of the HSE outlined plans for restructuring and reforming the…
End of Internet Subsidies for Low-Income Households Threatens Telehealth Access
The federal Affordable Connectivity Program covers $30 monthly internet bill payments for…
CPAP alternative may be better for lowering blood pressure in sleep apnea, hypertension
A study presented at the ACC Scientific Session and published in the…
Positive trial results set up Wegovy for heart failure application
A study presented at the American College of Cardiology conference and published…
Consultants in England accept improved pay offer
Consultants in England have voted to accept the government's improved pay offer,…
Oral vaccine for UTI is potential alternative to antibiotics, finds 9-year study
A long-term study presented at the European Association of Urology Congress in…
Researchers develop first genetic maps for disease-linked DNA repeats
The University of California, Irvine research team has created the first genetic…
How to Pick the Right Supplements for You
Various experts from prestigious institutions such as Northwestern University, Yale School of…